Why the study?
What is the natural history of severe symptomatic aortic valve stenosis with medical treatment in high-risk elderly patients?
What is the natural history of severe symptomatic aortic valve stenosis with medical treatment in high-risk elderly patients?
This review outlines the evidence on the natural history of severe symptomatic aortic stenosis with medical treatment to guide clinical decision-making in high-risk elderly patients.
Outlines historical medical outcomes in high-risk elderly with severe symptomatic AS; leaves open updated benchmarks versus contemporary interventions.
Aortic valve stenosis (AS) is increasingly observed in the clinic. Although at present surgical valve replacement is the gold standard in patients with severe symptomatic AS, elderly patients experience higher morbidity and mortality compared with younger patients. The emergence of transcatheter aortic valve implantation offers an alternative for high-risk or inoperable patients. However, mortality and morbidity is high and long-term outcomes, particularly with respect to device durability, are not yet available. The life expectancy of patients with severe symptomatic AS who are not operated upon is reduced. Most of the reported data, however, date back to the presurgical and precatheterization era. The aim of this article is to outline the evidence of natural history with medical treatment to assist in optimal clinical decision making in the high-risk elderly population with severe symptomatic AS.
No takes yet. Share an insight, caveat, or question.
Birim et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: